5) Humalog (insulin lispro) Humalog, a rapid-acting human insulin analog, is used for glycemic control in adults and children with diabetes mellitus
Medication typically ships within 710 business days after approval, often sooner with complimentary expedited shipping
75% of people taking GLP-1 medications report improved physical health, 68% feel more confident, and 56% say their mental health has improved
[DOI] [PubMed] [Google Scholar] 38.Gong J., et al
5 Nasal Application of Insulin Improves Cognition and Pathological Markers of AD To test the hypothesis that improving insulin signaling in the brain will show improvements in patients with AD, Suzanne Craft and colleagues conducted a series of experiments where patients with MCI or AD were treated with insulin
Then in April 2025, Pfizer announced the discontinuation of danuglipron itself after a case of potential drug-induced liver injury was identified in one participant during a dose-optimization study